颈淋巴结清扫术的淋巴结获取数预测头颈癌的抗肿瘤免疫反应
这项匹配队列研究在三级医疗中心标准化颈淋巴结清扫质量后评估384例受试者,将6例低淋巴结计数且低BMI的头颈癌患者与16例正常BMI且高淋巴结计数的患者按分期、p16状态和亚部位匹配。结果显示低BMI低淋巴结计数患者原发肿瘤中CD3、CD8、CD20细胞更少,成熟三级淋巴结构更少且密度更低,生存更差。
要点
- 低BMI且低淋巴结计数患者原发肿瘤CD3(p=0.0136)、CD8(p=0.0003)、CD20(p=0.0334)细胞显著少于正常BMI高淋巴结计数患者
- 低BMI低淋巴结计数患者成熟三级淋巴结构为0.83/肿瘤,正常BMI高淋巴结计数患者为5.4/肿瘤
- 低淋巴结计数仅在低BMI且非HPV相关肿瘤的HNSCC患者中预测生存更差
核心结论
- 低淋巴结计数仅在低BMI且非HPV相关肿瘤的HNSCC患者中预测生存更差,且在这些患者中与免疫抑制标志物相关,如肿瘤浸润CD8+ T细胞、CD20+细胞及原发癌中三级淋巴结构更少。
研究设计与样本
- 在三级医疗中心开展的匹配队列研究,标准化颈淋巴结清扫质量后共评估384例受试者。
- 将6例接受原发手术包括颈淋巴结清扫的低淋巴结计数(每个颈部区域≤5.6)且低BMI(<23)头颈癌患者,按分期、p16状态和亚部位与16例正常BMI且高淋巴结计数的患者匹配。
- 采用多重免疫组化评估肿瘤浸润淋巴细胞及原发肿瘤内三级淋巴结构的数量和质量,全原发癌切片经多重免疫组化染色后自动分析计数白细胞,由头颈病理学家盲法评分三级淋巴结构的数量和成熟度,使用描述性统计分析结果。
主要发现
- 低BMI低淋巴结计数患者原发肿瘤中CD3(p=0.0136)、CD8(p=0.0003)、CD20(p=0.0334)细胞显著少于正常BMI且淋巴结计数正常患者。
- 低BMI低淋巴结计数患者原发癌中成熟三级淋巴结构为0.83/肿瘤,正常BMI高淋巴结计数患者为5.4/肿瘤。
- 低BMI低淋巴结计数患者成熟三级淋巴结构密度(每μm²均值)为6.34×10⁻⁹,正常BMI高淋巴结计数患者为2.82×10⁻⁸,前者较后者低超过四倍。
- 低BMI低淋巴结计数患者生存较正常淋巴结计数的低BMI患者及正常BMI患者显著更差。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymph node count (LNC) from neck dissection has been associated with undernutrition and survival in head and neck squamous cell carcinoma (HNSCC). As local components of the immune system, cervical lymph nodes may reflect anti-tumor immune status. This study investigates the relationship between decreased LNC, formation of tertiary lymphoid structures (TLS), and primary tumor infiltration by lymphocytes in undernourished patients. METHODS: A matched-cohort study was conducted in a tertiary medical center, where neck dissection quality was standardized for a total of 384 subjects that were evaluated. Six head and neck cancer patients that underwent primary surgery including neck dissection with low LNC and BMI (low BMI < 23, low LNC ≤ 5.6 per neck level) were matched by stage, p16 status, and subsite to 16 patients with normal BMI and high LNC. Multiplexed immunohistochemistry was used to evaluate the tumor-infiltrating lymphocytes and the number and quality of TLS within primary tumors. Whole primary cancers underwent automated analysis and counting of leukocytes after multiplexed immunohistochemistry staining of tumor slides. A head and neck pathologist blindly scored the number and maturity of TLS. Descriptive statistics were used to analyze outcomes. RESULTS: The patients with low BMI and low LNC had significantly fewer CD3 (p = 0.0136), CD8 (p = 0.0003), and CD20 (p = 0.0334) cells in their primary tumors compared to patients with normal BMI and LNC. The low BMI low LNC patients also had fewer mature TLS (0.83/tumor) in their primary cancers compared to patients with normal BMI and high LNC (5.4/tumor) and also had greater than fourfold lower mature TLS density (TLS per μm2 mean) (6.34 × 10-9 vs. 2.82 × 10-8), with significantly worsened survival relative to patients with low BMI and normal LNC and patients with normal BMI. CONCLUSION: Low LNC predicts worsened survival only in low BMI HNSCC patients with non-HPV related tumors and in these patients is associated with markers of immunosuppression such as fewer tumor-infiltrating CD8+ T-cells, CD20+ cells, and fewer TLS in primary cancers compared to matched normal BMI patients with high LNC.
引用
- Chen S, Pyne JM, Liu Y, et al. Nodal Yield From Neck Dissection Predicts the Anti-Tumor Immune Response in Head and Neck Cancers. Head Neck. 2024. PMID: 39681999. doi:10.1002/hed.28006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。